Alnylam Pharmaceuticals, Inc.

FRANKLIN RESOURCES INC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

787,623

Value ($000)

313,198

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	313,198	0.1%	787,623	12/31/2025
2025 Q3	11/13/2025	325,589	0.1%	714,012	9/30/2025
2025 Q2	8/12/2025	196,088	0.1%	601,331	6/30/2025
2025 Q1	5/13/2025	123,754	0.0%	458,314	3/31/2025
2024 Q4	2/12/2025	97,451	0.0%	414,139	12/31/2024
2024 Q3	11/27/2024	108,504	0.0%	382,973	9/30/2024
2024 Q2	8/14/2024	70,306	0.0%	289,326	6/30/2024
2024 Q1	5/13/2024	35,498	0.0%	237,524	3/31/2024
2023 Q4	2/9/2024	28,889	0.0%	150,928	12/31/2023
2023 Q3	11/13/2023	26,617	0.0%	150,294	9/30/2023
2023 Q2	8/11/2023	28,561	0.0%	150,370	6/30/2023
2023 Q1	5/12/2023	32,210	0.0%	160,795	3/31/2023
2022 Q4	2/10/2023	38,225	0.0%	160,845	12/31/2022
2022 Q3	11/14/2022	31,886	0.0%	159,295	9/30/2022
2022 Q2	8/11/2022	22,770	0.0%	156,110	6/30/2022
2022 Q1	5/13/2022	31,298	0.0%	191,669	3/31/2022
2021 Q4	2/11/2022	35,664	0.0%	210,307	12/31/2021
2021 Q3	11/12/2021	28,257	0.0%	149,655	9/30/2021
2021 Q2	8/13/2021	611	0.0%	3,605	6/30/2021
2021 Q1	5/13/2021	436	0.0%	3,090	3/31/2021
2020 Q4	2/10/2021	466	0.0%	3,580	12/31/2020
2020 Q3	11/12/2020	18,239	0.0%	125,265	9/30/2020
2020 Q2	8/13/2020	19,594	0.0%	124,024	6/30/2020
2020 Q1	5/13/2020	13,545	0.0%	124,438	3/31/2020
2019 Q4	3/11/2020	14,573	0.0%	126,536	12/31/2019
2014 Q1	5/13/2014	174,523	0.1%	2,599,396	3/31/2014
2013 Q4	2/12/2014	137,930	0.1%	2,144,110	12/31/2013